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Introduction
Endoscopic retrograde cholangiopancreatography (ERCP)
is an invasive procedure that combines the use of endo-
scopy and fluoroscopy for diagnosing and treating many
pancreatic and biliary diseases. It has been used world-
wide for the last 40 years. Although a diagnosis may be
obtained non-invasively in certain conditions using
ultrasonography, helical computed tomography, and
magnetic resonance cholangiopancreatography, none
of these methods allow for therapeutic intervention1.
In developed countries, increasing proportions of
the population now survive to an advanced age with
progress in pharmaceutical technology, better intensive
medical care, and improvements in preventive medi-
cine2. As the population ages, the incidence of biliary
and pancreatic pathologies also increases3, leading to
an increased demand on the medical services to care
for these patients. By the age of 70, cholelithiasis and
choledocholithiasis are found in 33% of the population
of the United States4. Since the prevalence of bile duct
stones and malignant biliary disease and the risk of sur-
gery rise with age, ERCP is of particular value in elderly
patients. This review will focus on the indications, pre-
procedural preparation, sedation and analgesia, mon-
itoring/procedural care, complications, and outcomes
of diagnostic and therapeutic ERCP in the elderly.
Indication and Contraindication
Indications for ERCP have been proposed in a consensus
statement by the National Institutes of Health in 20025,
and several points were modified in a guideline pub-
lished by the American Society of Gastrointestinal
Endoscopy in 20056. The indications for ERCP among
the elderly are largely the same as those for adults, with
few variations in the relative frequency based upon the
development of age-related diseases, such as biliary
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tract disease, cancer, and gastrointestinal ischemia.
The absolute and relative contraindications are similar
to middle-aged or young adults, without respect to age.
However, decisions about therapeutic ERCP often
cannot be based on guidelines, because studies leading
to the guidelines have usually excluded older patients.
Decisions need to be made individually in view of the
increased risk caused by age-related diseases, such as
cardiac and pulmonary dysfunction. Significant risk may
outweigh the acknowledged benefits of a procedure.
Ethical issues are also raised by the use of diagnostic or
therapeutic procedures in patients with a limited life
expectancy. The procedures should be restricted to sit-
uations where life expectancy will likely be extended or
quality of life improved. Furthermore, physiologic age
and prognosis must be considered in the elderly.
Pre-procedural Preparation
The preparation of elderly undergoing ERCP is similar
to that used for upper gastrointestinal endoscopy.
Informed consent should be obtained and documented
before the patient is medicated. They must have ingested
no solid for at least 6 hours and no liquid for at least 4
hours before the procedure, which is the same as for
young adults7. Pharyngeal anesthesia is often admin-
istered in the form of lidocaine spray or other topical
agents. To reduce duodenal motility, parenteral glucagon
may be useful.
As elderly patients are more likely to have cardio-
vascular disease and implanted cardiac devices, one
must exercise caution with electrocautery use as there
is potential for inhibition of pacemaker or false detec-
tion of ventricular tachyarrhythmia8. Before the use of
electrocautery, pacemaker-dependent patients should
be programmed into an asynchronous pacing mode,
and intracardiac defibrillators should be inactivated.
Continuous rhythm monitoring must be used until 
the defibrillator is reactivated after the procedure.
Currently, there are well-defined recommendations
about management of patients with pacemaker and
implantable cardioverter defibrillators8–10.
Sedation and Analgesia
Most patients undergoing gastrointestinal endoscopy
require sedation or anesthesia. Guidelines concerning
conscious sedation and monitoring have been pub-
lished11,12. Because of the longer duration and more
potential discomfort of the ERCP procedure, conscious
sedation with intravenous benzodiazepines and frequent
addition of analgesic opiates are usually necessary.
Sedation in the elderly requires heightened attention to
dosing and the increased sensitivity of these patients
to standard sedatives. Decreased arterial oxygenation,
reduced hepatic and renal clearance, reduced volume
of distribution for pharmacologic agents, and increased
risk of aspiration contribute to the potential cardiopul-
monary complications of sedation in the elderly.
Drugs used for sedation in the elderly population
should have a short half-life, limited side effects, and be
administered at a slower rate and with a reduced total
dose. While midazolam and narcotics are commonly
used in younger patients, fentanyl has a quicker onset of
action and shorter half-life, and is safer than meperi-
dine in the elderly. Propofol is a respiratory depressant
with a narrow therapeutic window, but it has been
shown to be safe when used in elderly patients13,14.
Using lower initial doses of sedatives with gradual titra-
tion to effect is a helpful guide in sedating the elderly15.
Furthermore, to minimize the sedation risk, some
studies have demonstrated the role of unsedated
small-caliber endoscopy in elderly patients16–18.
Monitoring and Procedural Care
Patients who are elderly or have concomitant medical
problems may be at increased risk from sedation or
the procedure itself. These patients require more com-
plex or intensive monitoring around the time of endo-
scopic procedures. Appropriate attention to patient
monitoring before, during and after the procedure, will
help to minimize complications as well as to detect early
signs of distress, so that resuscitative measures can be
instituted.
Parameters for monitoring include significant
changes in pulse, blood pressure, oxygen saturation, car-
diac rhythm, and clinical and neurologic status. Contin-
uous electrocardiographic monitoring is routine in
high-risk patients, such as those with a history of car-
diac dysfunction or arrhythmia history, the elderly
population, and those in whom extensive procedures
are anticipated. Oxygen supplementation can reduce the
incidence of oxygen desaturation and should be used
in patients with known cardiopulmonary dysfunction19.
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Complications
A variety of complications, which can be categorized as
nonspecific (e.g., due to sedation or drug side effects) or
specific due to the procedure itself, have been described.
Most prospective series report an overall complication
rate for ERCP or sphincterotomy of about 5–10%20–23.
Five independent risk factors for complications identi-
fied by Freeman et al.23 included: difficult cannulation,
precut sphincterotomy, combined percutaneous-endo-
scopic procedure (method-related factors); sphincter
of Oddi dysfunction, and cirrhosis (patient-related fac-
tors). However, multivariate analyses have not shown
advanced age to increase the risk of overall complica-
tions of ERCP23. Several other studies have also shown
no relationship between complications after ERCP and
old age or coexisting medical conditions, except for liver
cirrhosis24,25. The post-ERCP complications were defined
according to published criteria24,26,27.
Post-ERCP Bleeding
Bleeding during ERCP is often observed after sphinc-
terotomy. About one-half of bleeding complications
occur immediately after sphincterotomy; a delay of 24
hours to several days is observed in other patients28–30.
Most bleeding episodes are graded as mild to moder-
ate in severity based upon a consensus definition26:
1. Mild: clinical evidence of bleeding (i.e., not just
endoscopic), hemoglobin drop of < 3 g/dL, and no
need for transfusion.
2. Moderate: need for transfusion (4 units or less),
with no angiographic intervention or surgery.
3. Severe: transfusion of 5 units or more, or need for
angiographic or surgical intervention.
Older series reported an incidence of post-endoscopic
sphincterotomy hemorrhage of 2–5%26. However, with
more experience and better techniques, the rate is 1–2%
in more recent studies21,23,31,32. Sugiyama et al. reported
ERCP-related bleeding in 2% of 70- to 89-year-old
patients33, similar to the rate of the young adults.
The risk is higher in those with coagulopathy, throm-
bocytopenia, cholangitis, large stones, presence of peri-
ampullary diverticulum and large sphincterotomy.
Thus, before the procedure, patients should be
screened for a history of excessive bleeding and the use
of anticoagulants or antiplatelet agents. A platelet
count and prothrombin time must also be routinely
checked, especially among extremely elderly patients
(age >90 years) who have significantly higher incidence
of chronic concomitant illness such as neurologic and
cardiovascular diseases34.
Post-ERCP Pancreatitis
Acute pancreatitis is the most common and serious
complications of ERCP26. It accounted for more than
one-half of complications of endoscopic sphinctero-
tomy in two large series23,35. In an analysis of 59 ERCP
lawsuits in North America, 30 cases and six of 15
deaths involved pancreatitis36. Acute post-procedure
pancreatitis is defined as a new or worsened abdomi-
nal pain with a rise in serum amylase at least three
times the upper limit of normal at more than 24 hours
after the procedure. It has three grades of severity26:
1. Mild: requiring admission or prolongation of a
planned admission to 2–3 days.
2. Moderate: hospitalization of 4–10 days.
3. Severe: hospitalization of more than 10 days, or
hemorrhagic pancreatitis, phlegmon or pseudocyst,
or required intervention (percutaneous drainage or
surgery).
Clarke et al.2 found post-ERCP pancreatitis occurring in
5% (1/21) of patients 85 years of age and older, similar to
the rate in younger patients23. Koklu et al.37 reported
that pancreatitis was more frequent in the younger
group (age ≤ 69 years [2.5%] vs. ≥ 70 years [1.0%]).
Rodriguez-Gonzalez et al.38 did not find post-ERCP
pancreatitis in their series. These findings may be related
to the presence of pancreatic atrophy associated with
advanced age20,33,39. Nevertheless, a correlation between
age and the frequency of post-ERCP pancreatitis was
not well demonstrated.
Post-ERCP Perforation
ERCP may be rarely complicated by perforation of the
esophagus, stomach, duodenum, or jejunum. The risk
is increased in patients with stenosis of any of these
segments and in patients who have undergone gas-
trectomy40. Retroperitoneal duodenal perforation is
most common, usually as a result of sphincterotomy.
It was reported in 0.5–2.1% of sphincterotomies in a
large series26, though the relationship between age and
the risk of perforation at ERCP was not mentioned.
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Post-ERCP Septic Complications
Infection is one of the most serious complications of
ERCP, including ascending cholangitis, liver abscess,
acute cholecystitis, infected pancreatic pseudocyst,
infection following perforation of a viscus, endocardi-
tis, and endovasculitis. The most frequent is ascending
cholangitis from incomplete stone clearance and
inadequate drainage of obstructed biliary system.
The elderly are more susceptible to infection 
with various pathogenic organisms than middle-aged
or young adults41. The age-related natural decline in
the immune status may contribute to increased infec-
tion-related morbidity and mortality with age42,43.
Thus, administration of prophylactic antibiotics before
ERCP in patients with biliary tract obstruction is 
necessary, especially in the elderly, and antibiotics
should be continued if drainage is incomplete or
fails44–46.
Rare Complications
A variety of rare complications have been reported,
such as gallstone ileus, colonic perforation, hepatic or
vascular trauma, pneumothorax, impaction of retrieval
baskets, complications related to biliary and pancre-
atic stents. However, the incidence has not been proven
to increase with age.
Other Risk Factors
In addition to the five independent risk factors for ERCP
complications identified by Freeman et al.23, several
additional risk factors have also been suggested in
other reports, including older age, comorbid diseases,
small bile duct diameter, emergent procedure, peri-
papillary diverticulum, and Billroth II gastrectomy47.
However, these conditions have not shown evidence
to increase the risk of overall complications of ERCP.
The prevalence of periampullary diverticula seems
to increase with age48. They can cause pancreatobiliary
reflux, bile-duct stone formation, or pancreatitis48,49.
They may also reduce the cannulation success rate
from 92% to 62%50. However, Katsinelos et al.34 stated
that periampullary diverticula did not cause technical
difficulties at ERCP or increase the risk of complica-
tions in elderly patients.
Outcomes
ERCP is safe and effective for diagnosis and treatment
of pancreatobiliary disease. It has been demonstrated
to be safe even itn elderly patients in the age range of
65–85 years2,37,51–53. Recent studies have shown that
ERCP in patients aged 90 years and above is safe and is
not significantly associated with an increased rate of
post-ERCP complications or mortality when compared
with those under the age of 9033,34,38,39,54,55. Neverthe-
less, these data are mainly from the West, and data
from the East is scarce. Chong et al. 56 reported that
ERCP is safe in the elderly Asian population, in agree-
ment with previous published studies from the West.
Death from ERCP is rare (0.5%) and most often
related to cardiopulmonary complications47,57. Although
older age is thought to be the common risk factor,
multivariate analyses have not substantiated it47.
Mortality has been shown to be related to severity of
illness and underlying malignancy, regardless of the
success of the procedure53,58.
Conclusion
ERCP is safe and effective in elderly patients, even in
those aged 90 years and older. Outcomes of diagnostic
and therapeutic ERCP in terms of success and compli-
cation rates are similar to those in younger patients.
Therefore, the decision to undergo ERCP should be
determined by clinical need, and age alone should not
be a contraindication to endoscopic intervention.
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